Indications
Treatment of Anxiety Disorders:
**Generalized Anxiety Disorder (GAD)
**Acute Anxiety
**Panic Disorder
**Anxiety associated with Depression
Warnings and Precautions
Use in the Elderly:
**Increased risk of falls and other side effects; use with caution
Concomitant Use with Alcohol or CNS Depressants:
**May enhance sedative effects and risk of respiratory depression
Use in Pregnancy and Lactation:
**Not recommended due to potential risks to the fetus and nursing infant
Abrupt Discontinuation:
**May lead to withdrawal symptoms such as seizures, anxiety, or depression
History and Background
Development and Registration:Trankimazin® is the brand name for alprazolam registered by Pfizer in Spain
Approval:Alprazolam was approved by the FDA in the United States in 1981
Misuse and Abuse
Overdose or Combination with Other Substances:
**Can lead to addiction, withdrawal symptoms, or severe side effects such as respiratory depression
Non-prescribed Use:
**Dangerous and illegal
Additional Information
Consideration in Patients with Depression or Suicidal Thoughts:
**Use with caution as it may increase the risk of such behaviors
Monitoring Treatment:
**Regular follow-up and dosage adjustments by healthcare professionals are essential
Reviews
There are no reviews yet.